OtherCardiovascular
A novel peptide agonist of FPRL1 (ALX) displays anti-inflammatory and cardioprotective effects
Iris Hecht, Rong Jiang, Andre LF Sampaio, Chen Hermesh, Caleb Rutledge, Ronen Shemesh, Amir Toporik, Merav Beiman, Liat Dassa, Hagit Niv, Gady Cojocaru, Arie Zauberman, Galit Rotman, Mauro Perretti, Jakob Vinten-Johansen and Yossi Cohen
Journal of Pharmacology and Experimental Therapeutics November 20, 2008, DOI: https://doi.org/10.1124/jpet.108.145821
Iris Hecht
Rong Jiang
Andre LF Sampaio
Chen Hermesh
Caleb Rutledge
Ronen Shemesh
Amir Toporik
Merav Beiman
Liat Dassa
Hagit Niv
Gady Cojocaru
Arie Zauberman
Galit Rotman
Mauro Perretti
Jakob Vinten-Johansen
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCardiovascular
A novel peptide agonist of FPRL1 (ALX) displays anti-inflammatory and cardioprotective effects
Iris Hecht, Rong Jiang, Andre LF Sampaio, Chen Hermesh, Caleb Rutledge, Ronen Shemesh, Amir Toporik, Merav Beiman, Liat Dassa, Hagit Niv, Gady Cojocaru, Arie Zauberman, Galit Rotman, Mauro Perretti, Jakob Vinten-Johansen and Yossi Cohen
Journal of Pharmacology and Experimental Therapeutics November 20, 2008, DOI: https://doi.org/10.1124/jpet.108.145821
OtherCardiovascular
A novel peptide agonist of FPRL1 (ALX) displays anti-inflammatory and cardioprotective effects
Iris Hecht, Rong Jiang, Andre LF Sampaio, Chen Hermesh, Caleb Rutledge, Ronen Shemesh, Amir Toporik, Merav Beiman, Liat Dassa, Hagit Niv, Gady Cojocaru, Arie Zauberman, Galit Rotman, Mauro Perretti, Jakob Vinten-Johansen and Yossi Cohen
Journal of Pharmacology and Experimental Therapeutics November 20, 2008, DOI: https://doi.org/10.1124/jpet.108.145821
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement